While some animal studies indicated superiority of certain strains of BCG in the treatment of NMIBC, a recent systematic review failed to identify any significant differences in recurrence across BCG strains â€“ Tokyo, Pasteur, and TICE all showed significant decreases in recurrence compared to intravesical chemotherapy for stage Ta, T1, or CIS disease [33].